Evidence map›Paper›PMID 15131110›Full record

ArticleThe Journal of biological chemistry2004

NCB5OR is a novel soluble NAD(P)H reductase localized in the endoplasmic reticulum.

Hao Zhu, Kevin Larade, Timothy A Jackson, Jianxin Xie, Annie Ladoux, Helmut Acker, Utta Berchner-Pfannschmidt, Joachim Fandrey, Andrew R Cross, Gudrun S Lukat-Rodgers and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Cytochrome bFree radical biology & medicine · 2026
    Article
  2. Article
  3. CytochromebioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontiers in molecular biosciences · 2022
    Article
  9. Crystal structures of the naturally fused CS and cytochrome bActa crystallographica. Section D, Structural biology · 2019
    Article
  10. Article
  11. Article
  12. Practicing biochemistry without a license.The Journal of biological chemistry · 2013
    Article
  13. Article
  14. Beta-Cell Injury in Ncb5or-null Mice is Exacerbated by Consumption of a High-Fat Diet.European journal of lipid science and technology : EJLST · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Hao ZhuHematology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. haozhu@rics.bwh.harvard.edu
Kevin Larade
Timothy A Jackson
Jianxin Xie
Annie Ladoux
Helmut Acker
Utta Berchner-Pfannschmidt
Joachim Fandrey
Andrew R Cross
Gudrun S Lukat-Rodgers
Kenton R Rodgers
H Franklin Bunn
Brigham and Women's Hospital · USRuhrlandklinik · DEScripps Research Institute · USMax Planck Institute of Molecular Physiology · DENorth Dakota State University · US

Funding

TARGETING AND DELIVERYP20RR015566 · NCRR · NORTH DAKOTA STATE UNIVERSITY · PI SINHA, SANGITA · 2001 to 2011
$19.0M
REGULATION OF SUPEROXIDE PRODUCTION BY HUMAN NEUTROPHILSR01AI024838 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDMAN, JEFFREY S · 1986 to 2007
$3.1M
OXYGEN SENSING AND SIGNAL TRANSDUCTIONR01DK056050 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BUNN, H. FRANKLIN · 1999 to 2003
$1.6M
Structural and Functional Analysis of Oxygen SensorK01DK059901 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI ZHU, HAO · 2001 to 2003
$272k
NCRR NIH HHS P20 RR015566NIAID NIH HHS R01 AI024838NIAID NIH HHS R01 AI24838NIDDK NIH HHS K01 DK059901NIDDK NIH HHS K01 DK59901NIDDK NIH HHS R01 DK056050NIDDK NIH HHS R01 DK56050
6 · The paper itself

Abstract

The NAD(P)H cytochrome b5 oxidoreductase, Ncb5or (previously named b5+b5R), is widely expressed in human tissues and broadly distributed among the animal kingdom. NCB5OR is the first example of an animal flavohemoprotein containing cytochrome b5 and chrome b5 reductase cytodomains. We initially reported human NCB5OR to be a 487-residue soluble protein that reduces cytochrome c, methemoglobin, ferricyanide, and molecular oxygen in vitro. Bioinformatic analysis of genomic sequences suggested the presence of an upstream start codon. We confirm that endogenous NCB5OR indeed has additional NH2-terminal residues. By performing fractionation of subcellular organelles and confocal microscopy, we show that NCB5OR colocalizes with calreticulin, a marker for endoplasmic reticulum. Recombinant NCB5OR is soluble and has stoichiometric amounts of heme and flavin adenine dinucleotide. Resonance Raman spectroscopy of NCB5OR presents typical signatures of a six-coordinate low-spin heme similar to those found in other cytochrome b5 proteins. Kinetic measurements showed that full-length and truncated NCB5OR reduce cytochrome c actively in vitro. However, both full-length and truncated NCB5OR produce superoxide from oxygen with slow turnover rates: kcat = approximately 0.05 and approximately 1 s(-1), respectively. The redox potential at the heme center of NCB5OR is -108 mV, as determined by potentiometric titrations. Taken together, these data suggest that endogenous NCB5OR is a soluble NAD(P)H reductase preferentially reducing substrate(s) rather than transferring electrons to molecular oxygen and therefore not an NAD(P)H oxidase for superoxide production. The subcellular localization and redox properties of NCB5OR provide important insights into the biology of NCB5OR and the phenotype of the Ncb5or-null mouse.

Indexed as

AnimalsBase SequenceBlotting, WesternCalreticulinCell LineChromatography, High Pressure LiquidComputational BiologyCOS CellsCytochrome-B(5) ReductaseCytochromes b5Cytochromes cDose-Response Relationship, DrugEndoplasmic ReticulumFemaleFerricyanidesHemeCalreticulinCytochrome-B(5) ReductaseCytochromes b5Cytochromes cFerricyanidesHemehexacyanoferrate IIIMethemoglobinNADH, NADPH OxidoreductasesOxygenRecombinant ProteinsSuperoxides

Identifiers

PMID15131110
PMCPMC3045664
OpenAlexW2129630264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.